Sagentia

Manufacturing Limited, to provide an integrated end-to-end research, development and manufacturing capability.

Together with its established Hong Kong manufacturing partner, AML, winner of the 2004 Hong Kong Grand Award for Industry and founding chairman of the Hong Kong Medical and Healthcare Device Manufacturers Association, Scientific Generics has launched SGAI Tech Limited (SGAI) which will be based in Hong Kong. Through SGAI, Scientific Generics and AML will leverage the combined benefits of Hong Kong's intellectual property laws and its proximity to China for the provision of a range of flexible, efficient and secure product development and manufacturing services to both new and existing clients.

Scientific Generics is investing HK$1.323 million for 63% of the equity of the JV and is providing a loan facility of up to HK$1.323 million. AIL is investing HK$0.777 million for 37% of the equity of the JV and is providing a loan facility of up to HK$0.777 million. A major key client has already been secured.

With the continued increase in off-shore manufacturing and the subsequent trend towards off-shoring of development, it is important that the ability to deliver innovative products in a cost effective and low-risk manner is not lost.

Recently Hong Kong has started to position itself as a technology transfer gateway to the South China manufacturing region. SGAI will utilise Hong Kong's growing knowledge based economy and high-tech infrastructure to link innovations from Cambridge through to production in China.

Combining the world-class innovation skills of Scientific Generics with the proven track record of AML, SGAI will focus on end-to-end delivery and provide clients with an integrated approach to innovative product development and production, which will mitigate the inherent commercial and technical risks of off-shoring.

Clients will benefit from increased flexibility and greater efficiency in the product development process. SGAI aims to offer a flexible method of charging for the cost of research and development - enabling companies with small R&D budgets but large purchasing power to specify and create their own innovative products. This will provide significant advantage to certain market sectors by affording them the ability to move away from 'me-too' products.

All manufacturing work will utilise the ISO 9001, ISO 13485, cGMP, FDA and SFDA compliant, QS 9000 approved manufacturing facilities of AML. These facilities, based in Dongguan, China, with 330,000 square feet of production facilities and a 4,000 strong work force, will enhance SGAI's range of capabilities from assembly design and proof-of-principle prototyping to testing, approval and full manufacture.

Dr Tim Moore, Managing Consultant at Scientific Generics, has been appointed Chief Executive Officer of SGAI.

Simon Davey, CEO, Scientific Generics, commented: 'The creation of SGAI represents a turning-point for hi-tech design consultancies in the UK. Linking Cambridge directly with Hong Kong and China enables us to translate clients needs into product realisation.

'Through an integrated innovative process SGAI will deliver outstanding quality in a low risk, efficient and rapid manner. Hong Kong is key to protecting intellectual property when developing products in China and its new research facilities, including the Hong Kong Science and Technology Park, make it an ideal place for mid-cap and start-up companies to leverage the value of China.'

John Mok, Chairman, AML, commented: 'SGAI will enable AML to build on its reputation for high quality and controlled manufacturing through access to new markets with innovative products. Based in Hong Kong and southern China, AML is ideally placed to take full advantage of the new Hong Kong economy through SGAI.'



SCIENTIFIC GENERICS
Scientific Generics is a leading international product development, technology licensing, and management consulting company.

Scientific Generics creates value from technology by:

Innovating and developing new technology platforms and products that fundamentally change the bases of competition; and

Assisting businesses and policy makers to design and implement strategies for technology, innovation and growth.

Scientific Generics has facilities and state-of-the-art laboratories located in Europe in Cambridge, Frankfurt and Stockholm; and in Boston and Baltimore in the USA.

THE GENERICS GROUP
Generics is a leading integrated technology consulting, development and investment organisation, with an international reputation for successfully commercialising emerging science and technology.



AUTOMATIC MANUFACTURING LIMITED
AML was founded in 1976 as a Hong Kong based electronic products manufacturing company. AML is an ISO 9001, ISO 13485, cGMP, FDA & SFDA compliant and QS 9000 approved manufacturer.

AML provides multi-technology design and manufacturing services for medical devices, automotive electronics, telecoms products, office equipment, home automation & industrial controls, etc. With recent expansion, AML owns around 330,000 square feet production facilities and has over 4,000 employees.

www.automatic.com.hk


*******

Contacts:

The Generics Group/Scientific Generics
Martin Frost, MD, The Generics Group
Simon Davey, CEO, Scientific Generics
+44 1223 875200


SGAI
Tim Moore, CEO, SGAI
+ 44 1223 875200
www.sgaitech.com

SGAI & AML
Peter Mok, Vice Chairman, AML, AIL & Director, SGAI
+ 852 2172 1228


Hansard Communications
Adam Reynolds / Andy Tan
+ 44 207 2451100